Kerecis

📍 Isafjordur, Iceland🗓 Founded 2011👥 293 employees💰 Last funded Nov 2012
Medical Equipment Manufacturing🌐 kerecis.com
Website LinkedIn
Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding cellular therapy and regenerative medicine market. The fatty-acid rich (including Omega3) products from the company's patented technologies enable the body to regenerate tissues, rather than simply repair them and risk scarring. The Kerecis products, which are based on Omega3 rich fish skin, are currently being used to regenerate tissue in trauma and chronic wounds such as burns and diabetic wounds. Kerecis is also developing products for areas such as oral surgery, plastic surgery and neurological applications. The vision of Kerecis is to extend human life by supporting the body’s own ability to regenerate. The Kerecis mission is to become the world leader in regenerating damage of the human body by sustainably harnessing nature’s own remedies.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2011
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Iceland
1
Frequently asked questions
Who invested in Kerecis?
Kerecis has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Kerecis last raise funding?
The most recent investment in Kerecis recorded on gritt.io was in November 2012.
When was Kerecis founded?
Kerecis was founded in 2011.
What industry is Kerecis in?
Kerecis operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Kerecis based?
Kerecis is headquartered in Isafjordur, Iceland.